U7D-1 | m-entrepreneurship.com

Product Name :
U7D-1

Search keywords :
U7D-1

drugId :
null

Target Vo:
Ubiquitin carboxyl-terminal hydrolase 7

Target Vo Short Name :
USP7

Moa_Name:
Ubiquitin carboxyl-terminal hydrolase 7 degraders

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences

Active Company_Name :
Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:
Preclinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-FOXO3a(Ser253) Antibody
KDM1A Antibody (YA718)
Ubiquitin Antibody (YA022): Ubiquitin Antibody (YA022) is a non-conjugated and Rabbit origined monoclonal antibody about 77 kDa, targeting to Ubiquitin. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts